Combination / selection rationale: A defined polyamine salt suits low-loading solids, requiring separate control of salt mass, spermidine equivalents and unit uniformity.
Published evidence / source details: A 2024 placebo-controlled trial in 37 men aged 50–70 studied high-purity spermidine trihydrochloride for up to 28 days. Clinical safety measures and serum/urine polyamines showed no substantial changes.
Development insights: Define declaration by salt or spermidine moiety and correct loading using an appropriate mass assay. Geometrically premix with filler and test transfer segregation, unit assay, moisture and barrier packaging; study loading is not a new-product intake recommendation.
Evidence scope: Short-term tolerance/exposure evidence, not longevity, autophagy efficacy or long-term safety.
2024 · Supplementation of spermidine at 40 mg/day has minimal effects on circulating polyamines: An exploratory double-blind randomized controlled trial in older men. · DOI 10.1016/j.nutres.2024.09.012 ↗